跳至主要内容
临床试验/NCT06544174
NCT06544174已完成不适用

Long-term Clinical Follow up After PCI for CTO

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 463 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
463
试验地点
1
主要终点
Major cardiovascular events (MACE)

研究概览

简要总结

The research aimed to evaluate the impact of a successful Percutaneous coronary intervention of chronic total occlusions (CTO-PCI) on long-term MACE (Major Cardiovascular Events), symptoms, survival, Left Ventricular Ejection Fraction (LVEF) and myocardial ischemia up-to-8-years follow-up.

详细描述

With this observational and prospective study, this research aimed to evaluate the impact of a successful CTO-PCI on long-term MACE (Major Cardiovascular Events), symptoms, survival, LVEF and myocardial ischemia up-to-8-years follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • who underwent at least one CTO procedure between 2025 and 2022 in Montpellier University Hospital
  • symptomatic of reversible myocardial ischemia
  • proof of myocardial viability

排除标准

  • refusal of the patient to participate to the study

结局指标

主要结局

Major cardiovascular events (MACE)

时间窗: Up to 8 years

Incidence of composite of cardiac death, non-fatal myocardial infarction and new target vessel revascularization

次要结局

  • Non combined MACE components(Up to 8 years)
  • Restenosis(Up to 8 years)
  • LVEF(Up to 8 years)
  • In-hospital events(Up to one week)
  • Ischemic burden(Up to 8 years)
  • Stent thrombosis(Within 30 days after the procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验